Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 463-471

  Derakhshandeh, Katayoun ^a   Soheili, Marzieh ^a   Dadashzadeh, Simin ^b   Saghiri, Reza ^c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

9 nitrocamptothecin; In vitro characterization; Long circulating nanoparticle

Indexed keywords

COPOLYMER; MACROGOL; NANOPARTICLE; POLYGLACTIN; RUBITECAN; 9-NITROCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG CARRIER; DRUG DERIVATIVE; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENCY; DRUG STABILITY; DRUG STRUCTURE; IN VITRO STUDY; NANOANALYSIS; NANOENCAPSULATION; NANOFABRICATION; NANOPHARMACEUTICS; PARTICLE SIZE; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE; THERMOSTABILITY; X RAY DIFFRACTION; ZETA POTENTIAL; BLOOD; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NANOMEDICINE; NEOPLASM; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CAMPTOTHECIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; POLYGLYCOLIC ACID; X-RAY DIFFRACTION;

EID: 79952118825     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s11586     Document Type: Article

References (38)

1. Panaym J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55:329-347.
2. Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology and continued development of the camptothecins. Clin Cancer Res. 2002;8:641-661.
3. Iyer L, Ratain MJ. Clinical pharmacology of camptothecins. Cancer Chem Pharm. 1998;42:S31-S34.
4. Erickson-Miller CL, May RD, Tomaszewski J, et al. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chem Pharm. 1997;39:467-472.
5. Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP. Mechanism of action of camptothecin. Ann N Y Acad Sci. 2000;922:1-10.
6. Fassberg J, Stella VJ. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci. 1992;81: 676-684.
7. Derakhshandeh K, Dadashzadeh S, Erfan M. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics. Eur J Pharm biopharm. 2007;66:34-41.
8. Lu W, Han X, Liu J, et al. 9- NC loaded folate-conjugated polymer micelles as tumor targeted drug delivery systems: preparation and evaluation in vitro. Int J Pharm. 2009;372:125-131.
9. Lu JL, Wang JC, Zhao SX, et al. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenograft in nude mice. Eur J Pharm Biopharm. 2008;69:899-907.
10. Arbuk SG, Takimoto CH. An overview of topoisomerase I targeting agents. Semin Hematol. 1998;35:3-12.
11. Dalwadi G, Sunderland B. An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles. Eur J Pharm Biopharm. 2009;71(2):231-242.
12. Beletsi A, Panagi Z, Avgoustakis K. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int J Pharm. 2005;298:233-241.
13. Yan X, Scherphof GL, Kamps JAAM. Liposome opsonization. J Liposome Res. 2005;15:109-139.
14. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release. 2005;109:169-188.
15. Peracchia MT, Harnisch S, Pinto-Alphandary H, et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials. 1999;20:1269-1275.
16. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93-102.
17. Porter CJH, Moghimi SM, Illum L, Davis SS. The polyoxyethylene polyoxypropylene block copolymer Poloxamer- 407 selectively redirects intravenously injected microspheres to sinusoidal endothelial-cells of rabbit bone-marrow. FEBS Letter. 1992b;305:62-66.
18. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263(5153):1600-1603.
19. Kwon GS, Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev. 1996;21:107-116.
20. Xiong XY, Li YP, Li ZL, et al. Vesicles from pluronic/poly (lactic acid) block copolymers as new carriers for oral insulin delivery. J Control Release. 2007;120(1-2):11-7.
21. Fernandez-Carballoido A, Pastoriza P, Barica E, Montejo C, Negro S. PLGA/PEG derivative polymeric matrix for drug delivery system application: characterization and cell viability studies. Int J Pharm. 2008;352:50-57.
22. Letchford K, Burt H. A review of the formulation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm. 2007;65(3):259-269.
23. Paciotti GF, Kingston DGI, Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctionaltumortargeted drug delivery vectors. Drug Deliv Res. 2006;67:47-54.
24. Klumpp C, Kostarelos K, Prato M, Bianco A. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochimica et Biophysica Acta. 2006;1758:404-412.
25. Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials. 2006;27:4356-4373.
26. Kostarelos K. Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science. Adv Colloid Interface Sci. 2003;106:147-168.
27. Hubbell JA. Enhancing drug function. Science. 2003;300:595-596.
28. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818-1822.
29. Savic R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 2003;300: 615-618.
30. Danhier F, Lecouturier N, Vroman B, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Control Release. 2009;133:11-17.
31. Hu Y, Xie J, Tong YW, Wang CH. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release. 2007;118(1):7-17.
32. Burt HM, Liggins RT. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev. 2002;54:191-202.
33. Liu W, Yang A, Yang L, Li Z, Xu H, Yang X. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. Int J Pharm. 2007;331:123-132.
34. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGAmPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 2002;79:123-135.
35. Baker RW, Lonsdale HK. Controlled release of biologically active agent. in: AC Tanquary, R Lacey, eds. New York: Plenum Press. 1974; p. 15-71.
36. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. 1. Theoretical consideration. Ind Eng Chem. 1931;23: 923-931.
37. Gao J, Ming J, Hec B, Fanc Y, Guc Z, Zhang X. Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery. Eur J Pharm Sci. 2008;34:85-93.
38. Gao JM, Ming J, He B, Gu ZW, Zhang XD. Controlled release of 9-nitro-20(S)-camptothecin from methoxy poly(ethylene glycol)- poly(D,L-lactide) micelles. Biomed Mater. 2008;3:015013.